Enter to open, tab to navigate, enter to select
Endo International plc and Par Pharmaceutical Holdings, Inc. merger
| May 18, 2015 • Private Acquisition Agreements • $8.05 billion (approximate deal value based on the 10-day volume weighted average share price of Buyer Parent's common stock ending on May 15, 2015; subject to purchase price adjustment). |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.